Andrea Fleig Selected Research

Insulin Resistance

6/2010

TRPM5 regulates glucose-stimulated insulin secretion.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Andrea Fleig Research Topics

Disease

7	Neoplasms (Cancer) 01/2024 - 11/2011
4	Inflammation (Inflammations) 01/2024 - 07/2008
2	Stroke (Strokes) 01/2024 - 12/2020
2	Nausea 01/2024 - 01/2022
2	Epilepsy (Aura) 01/2024 - 01/2022
2	Kidney Diseases (Kidney Disease) 01/2024 - 01/2023
2	Pain (Aches) 01/2024 - 01/2022
2	Vomiting 01/2024 - 01/2022
2	Brain Injuries (Brain Injury) 01/2021 - 12/2020
2	Brain Ischemia (Cerebral Ischemia) 12/2020 - 01/2018
2	Hyperglycemia 01/2018 - 06/2010
2	Colonic Neoplasms (Colon Cancer) 11/2017 - 01/2017
1	Hypoxia (Hypoxemia) 02/2023
1	Fibrosis (Cirrhosis) 01/2023
1	Ureteral Obstruction 01/2023
1	Chronic Renal Insufficiency 01/2023
1	Muscle Spasticity (Spastic) 01/2022
1	Chronic Pain 01/2022
1	Pathologic Processes 01/2021
1	Glioblastoma (Glioblastoma Multiforme) 12/2020
1	Central Nervous System Diseases (CNS Diseases) 12/2020
1	Atrophy 11/2020
1	Insulinoma 10/2017
1	Aberrant Crypt Foci 01/2017
1	Carcinogenesis 01/2017
1	Adenocarcinoma 01/2017
1	Colorectal Neoplasms (Colorectal Cancer) 01/2017
1	Hypersensitivity (Allergy) 12/2014
1	Neuroblastoma 09/2014
1	Cardiovascular Diseases (Cardiovascular Disease) 01/2014
1	Ischemia 01/2014
1	Breast Neoplasms (Breast Cancer) 08/2013
1	Asthma (Bronchial Asthma) 05/2013
1	Parkinson Disease (Parkinson's Disease) 01/2013
1	Type 2 Diabetes Mellitus (MODY) 06/2010
1	Insulin Resistance 06/2010
1	Infections 07/2008
1	Colitis 07/2008
1	Autoimmune Diseases (Autoimmune Disease) 01/2008
1	Multiple Sclerosis 01/2008
1	Psoriasis (Pustulosis Palmaris et Plantaris) 01/2008
1	Type 1 Diabetes Mellitus (Autoimmune Diabetes) 01/2008

Drug/Important Bio-Agent (IBA)

6	waixenicin AIBA 02/2023 - 11/2011
4	MagnesiumIBA 01/2018 - 01/2014
3	CannabinoidsIBA 01/2024 - 01/2022
3	CationsIBA 01/2021 - 09/2014
3	Proteins (Proteins, Gene)FDA Link 12/2020 - 06/2010
2	CytokinesIBA 01/2022 - 05/2013
2	CalciumIBA 01/2018 - 05/2013
2	Glucose (Dextrose)FDA LinkGeneric 01/2018 - 06/2010
2	AzoxymethaneIBA 11/2017 - 01/2017
2	Reactive Oxygen Species (Oxygen Radicals)IBA 05/2013 - 07/2008
1	CannabidiolIBA 01/2024
1	Dronabinol (THC)FDA LinkGeneric 01/2024
1	Mitogen-Activated Protein Kinase Kinases (MEKs)IBA 02/2023
1	Cisplatin (Platino)FDA LinkGeneric 01/2023
1	EndocannabinoidsIBA 01/2023
1	Plant ExtractsIBA 01/2022
1	Calcium-Calmodulin-Dependent Protein KinasesIBA 01/2021
1	CalcineurinIBA 01/2021
1	Phosphotransferases (Kinase)IBA 01/2021
1	(R)- N- (benzimidazol- 2- yl)- 1,2,3,4- tetrahydro- 1- naphthylamineIBA 11/2020
1	scalaradialIBA 10/2017
1	Small Interfering RNA (siRNA)IBA 09/2014
1	ChloridesIBA 08/2013
1	sodium-iodide symporter (sodium iodide symporter)IBA 08/2013
1	IodidesIBA 08/2013
1	AllergensIBA 05/2013
1	OvalbuminIBA 05/2013
1	AntibodiesIBA 05/2013
1	Transient Receptor Potential ChannelsIBA 05/2013
1	Aluminum Hydroxide (Algeldrate)FDA Link 05/2013
1	Ion Channels (Ion Channel)IBA 05/2013
1	Blood Glucose (Blood Sugar)IBA 06/2010
1	Arginine (L-Arginine)FDA Link 06/2010
1	Dextran SulfateIBA 07/2008
1	ChemokinesIBA 07/2008
1	Kv1.3 Potassium ChannelIBA 01/2008

Therapy/Procedure

1	Drug Therapy (Chemotherapy) 01/2024
1	Therapeutics 11/2011